Key committee to consider FDA authorization for Pfizer/BioNTech Covid-19 vaccine

There's not much suspense going into Thursday's meeting of the US Food and Drug Administration's vaccine advisers, who will discuss emergency use authorization for Pfizer and BioNTech's coronavirus vaccine.